Robert Resnick

Robert Resnick is a seasoned research professional with extensive experience in pharmacology and immunology. Currently serving as Principal Scientist in In vivo Pharmacology at AbCellera since January 2024, Robert previously held the position of Associate Director of Immunology at ImmuneID, where responsibilities included establishing an immunology group and leading a team to identify novel therapeutic targets. Robert's career at Sanofi spanned over 16 years, during which time responsibilities included developing multispecific drugs for asthma and atopic dermatitis, leading high-priority projects, and ensuring compliance with company guidelines. Robert's early career involved key laboratory roles focused on modeling various health conditions, including hemoglobinopathies and neuronal tumors, establishing a strong foundation in biomedical research. Robert holds a Bachelor of Science degree in Biomedical Technologies from the University of Vermont.